Top

EJNMMI Research

Published in:

Open Access 01-12-2017 | Original research

IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms

Authors: Martin Andersson, Lennart Johansson, Keith Eckerman, Sören Mattsson

Published in: EJNMMI Research | Issue 1/2017

Abstract

Background

To date, the estimated radiation-absorbed dose to organs and tissues in patients undergoing diagnostic examinations in nuclear medicine is derived via calculations based on models of the human body and the biokinetic behaviour of the radiopharmaceutical. An internal dosimetry computer program, IDAC-Dose2.1, was developed based on the International Commission on Radiological Protection (ICRP)-specific absorbed fractions and computational framework of internal dose assessment given for reference adults in ICRP Publication 133. The program uses the radionuclide decay database of ICRP Publication 107 and considers 83 different source regions irradiating 47 target tissues, defining the effective dose as presented in ICRP Publications 60 and 103. The computer program was validated against another ICRP dosimetry program, Dose and Risk Calculation (DCAL), that employs the same computational framework in evaluation of occupational and environmental intakes of radionuclides. IDAC-Dose2.1 has a sub-module for absorbed dose calculations in spherical structures of different volumes and composition; this sub-module is intended for absorbed dose estimates in radiopharmaceutical therapy. For nine specific alpha emitters, the absorbed dose contribution from their decay products is also included in the committed absorbed dose calculations.

Results

The absorbed doses and effective dose of ¹³¹I-iodide determined by IDAC-Dose2.1 were validated against the dosimetry program DCAL, showing identical results. IDAC-Dose2.1 was used to calculate absorbed doses for intravenously administered ¹⁸F-FDG and orally administered ^99mTc-pertechnetate and ¹³¹I-iodide, three frequently used radiopharmaceuticals. Using the tissue weighting factors from ICRP Publication 103, the effective dose per administered activity was estimated to be 0.016 mSv/MBq for ¹⁸F-FDG, 0.014 mSv/MBq for ^99mTc-pertechnetate, and 16 mSv/MBq for ¹³¹I-iodide.

Conclusions

The internal dosimetry program IDAC-Dose2.1 was developed and applied to three radiopharmaceuticals for validation against DCAL and to generate improved absorbed dose estimations for diagnostic nuclear medicine using specific absorbed fraction values of the ICRP computational voxel phantoms. The sub-module for absorbed dose calculations in spherical structures 1 mm to 9 cm in diameter and different tissue composition was included to broaden the clinical usefulness of the program. The IDAC-Dose2.1 program is free software for research and available for download at http://www.idac-dose.org.

Eckerman K, Leggett R, Cristy M, Nelson C, Ryman J, Sjoreen A, Ward R. DCAL: User's guide to the DCAL system. ORNL/TM-2001/190. Oak Ridge National Laboratory. ANNEXE. 2006.

Johansson L. Patient irradiation in diagnostic nuclear medicine: assessment of absorbed dose and effective dose equivalent dosimetry [doctoral thesis]. Gothenburg, Sweden: Gothenburg University; 1985.

Andersson M, Johansson L, Minarik D, Mattsson S, Leide Svegborn S. An upgrade of the internal dosimetry computer program IDAC. In: Adlienè D, editor. Medical physics in the Baltic states 2012. Kaunas: Technologija; 2012. p. 120–3.

Stabin M. MIRDOSE: personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 1996;37:538–46.PubMed

Stabin M, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023–7.PubMed

ICRP. Radiation dose to patients from radiopharmaceuticals. Publication 53. Ann ICRP. 1988;18(1–4):1-377.

ICRP. Radiation dose to patients from radiopharmaceuticals:(addendum 2 to ICRP publication 53). Publication 80. Ann ICRP. 1998;28(3):1-123.

ICRP. Radiation dose to patients from radiopharmaceuticals. Addendum 3 to ICRP publication 53. Publication 106. Ann ICRP. 2008;38(1–2)

ICRP. Radiation Dose to Patients from Radiopharmaceuticals. A compendium of current information related to frequently used substances. ICRP publication 128. Ann ICRP. 2015;44(2S):1–321.

10.

ICRP. Age-dependent doses to members of the public from intake of radionuclides—part 1. ICRP publication 56. Ann ICRP. 1990;20(2):1-197.

11.

ICRP. Age-dependent doses to members of the public from intake of Radionuclides—part 2 ingestion dose coefficients. ICRP publication 67. Ann ICRP. 1993;23(3–4):1-167.

12.

ICRP. Age-dependent doses to members of the public from intake of Radionuclides—part 3 ingestion dose coefficients. ICRP publication 69. Ann ICRP. 1995;25(1):1-74.

13.

ICRP. Age-dependent doses to members of the public from intake of Radionuclides—part 4 inhalation dose coefficients. ICRP publication 71. Ann ICRP. 1995;25(3–4):1-405.

14.

ICRP. Age-dependent doses to members of the public from intake of Radionuclides—part 5 compilation of ingestion and inhalation coefficients. ICRP publication 72. Ann ICRP. 1995;26(1):1-91.

15.

ICRP. Compendium of dose coefficients based on ICRP publication 60. ICRP publication 119. Ann ICRP. 2012;41(S):1-130.

16.

Cristy M., Eckerman K. Specific absorbed fractions of energy at various ages from internal photons sources. ORNL/TM-8381 V1-V7. Oak Ridge National Laboratory. 1987.

17.

ICRP. Report of the task group on reference man. ICRP publication 23. Oxford: Pergamon Press; 1975.

18.

ICRP. Basic anatomical and physiological data for use in radiological protection. ICRP publication 89. Reference values. Ann ICRP. 2002;32(3–4):1-277.

19.

ICRP. The 2007 recommendations of the international commission on radiological protection. ICRP publication 103. Ann ICRP. 2007;37(2–4):1-332.

20.

ICRP. Adult reference computational phantoms. ICRP publication 110. Ann ICRP. 2009;39(2):1-165.

21.

ICRP. The ICRP computational framework for internal dose assessment for reference adults: specific absorbed fractions. ICRP publication 133. Ann ICRP. 2016;45(2):1-73.

22.

ICRP. Nuclear decay data for dosimetric calculations. ICRP publication 107. Ann ICRP. 2008;38(3):1-96.

23.

Andersson M, Johansson L, Minarik D, Mattsson S, Leide-Svegborn S. An internal radiation dosimetry computer program, IDAC2.0, for estimation of patient dose for radiopharmaceuticals. Radiat Prot Dosim. 2014;162:299–305.CrossRef

24.

Zankl M, Schlattl H, Petoussi-Henss N, Hoeschen C. Electron specific absorbed fractions for the adult male and female ICRP/ICRU reference computational phantoms. Phys Med Biol. 2012;57:4501–26.CrossRefPubMed

25.

ICRP. Occupational intakes of radionuclides: part 1. ICRP publication 130. Ann ICRP. 2015;44(2):1-188.

26.

ICRP. Occupational intakes of radionuclides: part 2. ICRP publication 134. Ann ICRP. 2016;45(3/4):1-351.

27.

Bolch WE, Eckerman KF, Sqouros G, Thomas SR. MIRD pamphlet no. 21: a generalized schema for radiopharmaceutical dosimetry—standardization of nomenclature. J Nucl Med. 2009;50:477–4.CrossRefPubMed

28.

ICRP. Radionuclide transformations—energy and intensity of emissions. ICRP publication 38. Oxford: Pergamon Press; 1975.

29.

Snyder W. Estimates of absorbed fraction of energy from photon sources in body organs. In: Medical radionuclides: radiation dose and effects. Oak Ridge, TN, USA: USAEC Division of Technical Information Extension; 1970. p. 33–50.

30.

Berger M. Energy deposition in water by photons from point isotropic sources. MIRD pamphlet no. 2. J Nucl Med. 1968:915–25.

31.

Siegel JA, Stabin MG. Absorbed fractions for electrons and beta particles in spheres of various sizes. J Nucl Med. 1994;35:152–6.PubMed

32.

Goorley T, et al. Initial MCNP6 release overview. Nucl Technol. 2012;180:298–315.CrossRef

33.

Bateman H. Solution of a system of differential equations occurring in the theory of radioactive transformations. Proc Camb Philos Soc. 1910;15:423–7.

34.

Killough GG, Eckerman KF. A conversational Eigen analysis program for solving differential equations. In: Kathren RL, Higby DP, MA MK, editors. Computer applications in health physics. Proceedings of the 17^th midyear topical symposium of the Health Physics Society. Richland, WA: Columbia Chapter, HPS; 1984. p. 4. 49-4,58.

35.

Boellaard R, Delgado-Bolton R, Oyen WJ, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328–54.CrossRefPubMed

36.

Leggett R, Giussani A. A biokinetic model for systemic technetium in adult humans. J Radiol Prot. 2015;35:297–315.CrossRefPubMed

37.

Leggett RW. A physiological systems model for iodine for use in radiation protection. Radiat Res. 2010;174:496–516.CrossRefPubMed

38.

Hadid L, Gardumi A, Desbree A. Evaluation of absorbed and effective doses to patients from radiopharmaceuticals using the ICRP 110 reference computational phantoms and ICRP 103 formulation. Radiat Prot Dosim. 2013;156:141–59.CrossRef

39.

Andersson M, Johansson L, Minarik D, Leide-Svegborn S, Mattsson S. Effective dose to adult patients from 338 radiopharmaceuticals estimated using ICRP biokinetic data, ICRP/ICRU computational reference phantoms and ICRP 2007 tissue weighting factors. EJNMMI Phys. 2014;1:9.CrossRefPubMedPubMedCentral

40.

Andersson M. Erratum to: effective dose to adult patients from 338 radiopharmaceuticals estimated using ICRP biokinetic data, ICRP/ICRU computational reference phantoms and ICRP 2007 tissue weighting factors. EJNMMI Phys. 2015;2:22.CrossRefPubMedPubMedCentral

Title: IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms
Authors: Martin Andersson
Lennart Johansson
Keith Eckerman
Sören Mattsson
Publication date: 01-12-2017
Publisher: Springer Berlin Heidelberg
Published in: EJNMMI Research / Issue 1/2017
Electronic ISSN: 2191-219X
DOI: https://doi.org/10.1186/s13550-017-0339-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

IDAC-Dose 2.1, an internal dosimetry program for diagnostic nuclear medicine based on the ICRP adult reference voxel phantoms

Abstract

Background

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2017

New approaches for the reliable in vitro assessment of binding affinity based on high-resolution real-time data acquisition of radioligand-receptor binding kinetics

Characteristics of immunoglobulin G4-related aortitis/periaortitis and periarteritis on fluorodeoxyglucose positron emission tomography/computed tomography co-registered with contrast-enhanced computed tomography

Three-minute SPECT/CT is sufficient for the assessment of bone metastasis as add-on to planar bone scintigraphy: prospective head-to-head comparison to 11-min SPECT/CT

Comparison of diagnostic performance of four software packages for phase dyssynchrony analysis in gated myocardial perfusion SPECT

Quantitative evaluation of oxygen metabolism in the intratumoral hypoxia: 18F-fluoromisonidazole and 15O-labelled gases inhalation PET

O-(2-[18F]fluoroethyl)-l-tyrosine PET in gliomas: influence of data processing in different centres